XLO
MODERATEXilio Therapeutics, Inc.
CIK: 0001840233
Sell
(30% confidence)
Last activity: Jan 2, 2026
Financial Metrics
As of Dec 31, 2024 (10-K)
Net Income -$75.80M
Insider Roster (2 total, 2 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Frankenfield Christopher James Chief Financial Officer | 0 | 1 | -$5K | 24,766 shares $16K |
| Brennan Kevin M. SVP, FINANCE AND ACCOUNTING | 0 | 1 | -$1K | 6,371 shares $4K |
Recent Transactions
SELL Frankenfield Christopher James (Chief Financial Officer)
7,030 shares @ $0.64
$5K
Jan 2, 2026
Conviction: |
View SEC Filing →
SELL Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING)
1,826 shares @ $0.64
$1K
Jan 2, 2026
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.